Clinical TrialsSearch results
Number of results: 212
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Other
- A phase II randomized study of DP(Docetaxel+Cisplatin),DJ(Docetaxel+Carboplatin),and TJ(Paclitaxel+Carboplatin) in patients with advanced and recurrent endometrial carcinoma
- advanced or recurrent endometrial carcinoma
- Japanese Gynecologic Oncology Group
- 2005-09-15
Other
- A phase II study of Irinotecan (CPT-11) for Leiomyosarcoma of Uterus
- Leiomyosarcoma of Uterus
- Japanese Gynecologic Oncology Group
- 2006-07-13
Other
- A PhaseII trial of oral etopocide and iv irinotecan for patients with platinum resistant and taxane pretreated ovarian cancer(JCOG0503)
- platinum resistant and taxane pretreated ovarian cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-04-01
Other
- A prospective cohort study of peginterferon alpha-2a plus ribavirin treatment in patients with chronic hepatitis C.
- Chronic hepatitis C
- Okayama University Hospital
- 2008-02-29
Other
- A prospective observation study concerning the incidence of atherothrombotic events in patients with acute coronary syndrome.
- Acute coronary syndrome
- Sanofi K.K.
- 2008-05-10
Other
- A randomized controlled study comparing Anastrozole+TS-1 as postoperative chemotherapy in ER positive metastatic breast cancer
- Breast Cancer
- Department of Breast and Thyroid Surgery, Kawasaki Medical School
- 2007-08-12
Other
- A randomized controlled study comparing S-1 with UFT as postoperative adjuvant Chemotherapy in Rectal Cancer.
- Rectal Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-04-01
Other
- A Randomized Phase II Clinical Trial of Tailored CPT-11 + S-1 vs S-1 in Patients with Advanced or Recurrent Gastric Carcinoma as the First Line Chemotherapy
- Advanced or recurrent gastric cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2005-08-31
Other
- A randomized phase III trial of AP(Doxorubicin+Cisplatin) versus DP(Docetaxel+Cisplatin), TC(Paclitaxel+Carboplatin) as adjuvant chemotherrapy in patients with high risk group of endometrial carcinoma
- patients with high risk group of endometrial carcinoma which is removed surgically
- Japanese Gynecologic Oncology Group
- 2006-11-15